Woman Suffers Tardive Dyskinesia from Reglan Use

An individual lawsuit has been filed by attorneys at Searcy Denney in the Court of Common Pleas in Philadelphia County.

This case is one of several thousand that have been filed in the coordinated mass torts proceedings against the manufacturers of Reglan and metoclopramide.  This lawsuit was filed on behalf of a New York resident who ingested name brand Reglan and generic formulations of metoclopramide, manufactured by:

• Bristol-Myers Squibb, Apothecon
• Invamed, Geneva Pharmaceuticals, Inc.
• Sandoz, Inc., Qualitest
• Beach Products, Inc.
• Pharmaceutical Assoc., Inc.,
• Barr Laboratories

This unfortunate young woman took Reglan for nine years to treat her gastroesophageal reflux disease (GERD).  She has been diagnosed with tardive dyskinesia and other movement disorders, which have been linked to chronic use of Reglan.

The FDA issued a Black Box warning in February of 2009, alerting physicians and patients that a significant percentage of patients who ingest Reglan for long periods of time have developed movement disorders, which can include restless leg syndrome, facial tics, chorea, and other significantly debilitating neurological disorders.  It is anticipated that a significant number of additional cases will be filed in the Philadelphia proceedings in the coming days in advance of the two-year anniversary on February 26, 2011, of the Black Box warning.